Navigation Links
The Convergent Procedure for the Treatment of Chronic Atrial Fibrillation Highlighted at EACTS Annual Meeting in Geneva
Date:9/13/2010

MORRISVILLE, N.C., Sept. 13 /PRNewswire/ -- The Convergent Procedure, a novel approach to treat atrial fibrillation (AF), enabled by epicardial ablation products from nContact Surgical, Inc. (nContact), was highlighted at the Techno-College Atrial Fibrillation Session of the EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting in Geneva, Switzerland. More than 1,000 medical professionals attended the 2010 Techno-College Programme to receive an update on the latest technical advancements in cardiothoracic surgery.

The Convergent Procedure is the first multidisciplinary, closed chest treatment for all types of AF.  During the combined epicardial-endocardial ablation procedure, a cardiac surgeon and an electrophysiologist (EP) work as a team to create a comprehensive bi-atrial lesion pattern, without chest incisions or ports. The surgeon utilizes the nContact coagulation device during epicardial ablation to create continuous, linear lesions on a beating heart. The EP then performs endocardial ablation to complete the pattern and utilizes mapping and diagnostics to ensure lesion completeness and that procedure endpoints are achieved.  

Professor Borut Gersak, Head of Cardiovascular Surgery at the University Medical Center, Ljubljana, Slovenia, presented the Convergent Procedure technique and long-term outcomes of 53 patients at six months and 39 patients at twelve months.  Data from the study confirmed over 90% of patients returned to sinus rhythm at six and twelve months post-procedure.  

Commenting on the positive patient data and advantages of the Convergent Procedure, Professor Gersak stated, "The Convergent Procedure merges the best techniques of two cardiac disciplines into a single, complete epicardial-endocardial approach that offers a new treatment opportunity for persistent and longstanding persistent AF patients."

Professor Gerhard Wimmer-Greinecker, Chief of Cardiac Surgery at the Heart
'/>"/>

SOURCE nContact Surgical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices
2. Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction
3. Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures
4. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
5. Leading Cardiovascular Surgeons Gather from Around the World to Share Ross Procedure Survival Data, Techniques at 2nd Annual Summit
6. CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China
9. VerteLoc™ Tops 500 Surgical Procedures, VGI Announces VerteLX™ and Seeks Potential Investors for Growth
10. DHS Begins Test of Biometric Exit Procedures at Two U.S. Airports
11. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014  The 12th ... officially kicks off September 29 at the John ... over Boston for a weeklong ... Cold Chain Global Forum is designed to cover the ... the modern cold chain, all temperature range products, GDP ...
(Date:9/29/2014)... 29, 2014  Perrigo Company plc (NYSE: ... has transferred a portfolio of preclinical research assets, ... of Elan Corporation plc, to drug discovery and ... agreement, Perrigo will receive an upfront payment in ... on any future sales derived from the portfolio. ...
(Date:9/29/2014)... , Sept. 29, 2014  Xcenda, the strategic ... global pharmaceutical sourcing and distribution service companies, recently ... consumption. This research was analyzed in an economic ... associated with an increase in life years and ... at population-level coffee consumption across the ...
(Date:9/29/2014)... 29, 2014 Westbridge Agricultural Products ... EC, a highly effective new tool for organic ... broad spectrum contact herbicide for post-emergent, non-selective weed ... non-food crops. The formulation is an emulsifiable concentrate ... Review Institute (OMRI) for use in organic food ...
Breaking Biology Technology:12th Cold Chain GDP & Temperature Management Logistics Global Forum Officially Kicks Off in Boston 2Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 2Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 3Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 4Coffee Consumption May Increase Survival and Reduce Healthcare Costs 2Coffee Consumption May Increase Survival and Reduce Healthcare Costs 3Westbridge Receives EPA Approval for Its New SUPPRESS™ Herbicide EC 2
... 29, 2012 Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: ... to sell, subject to customary closing conditions, $40 million of ... to purchase shares of its common stock (and the shares ... of the Series 15 Convertible Preferred Stock and exercise and ...
... and TARRYTOWN, New York, May 26, 2012 ... SNY ) and Regeneron Pharmaceuticals, Inc. (NASDAQ: ... a Phase 2 trial of SAR236553/REGN727 (Study 1003, ... SAR236553/REGN727 is a subcutaneously administered, fully-human antibody targeting ...
... known that a diet high in fat and extremely low ... But how the diet worked, and why, was a mysteryso ... called it "Epilepsy,s Big, Fat Miracle." Now, researchers ... an answer, linking resistance to seizures to a protein that ...
Cached Biology Technology:Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 2Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 3Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 4Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 5Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock 6Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 2Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 3Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 4Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 5Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 6Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 7Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 8Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet 9Reverse engineering epilepsy's 'miracle' diet 2Reverse engineering epilepsy's 'miracle' diet 3
(Date:9/29/2014)... DETROIT In order to support the world,s ... chemicals, polymers and more, new and more efficient ... team of researchers, including several from Wayne State ... of a new grant from the National Science ... Guided Design of Multicomponent Materials for Electrocatalytic Cascade ...
(Date:9/29/2014)... Scientists at Washington State University have concluded ... Smith apples may help prevent disorders associated ... first to assess these compounds in apple cultivars ... print edition of the journal Food Chemistry ... a good source of these nondigestible compounds but ...
(Date:9/29/2014)... Santos has presented Dr. Cristin Samper, president and ... prestigious Order of San Carlos. , The Order ... and military officers who have made outstanding contributions ... international relations. , An international authority on conservation ... to the Colombian Residence in New York to ...
Breaking Biology News(10 mins):Wayne State research aims to develop new, more efficient catalytic materials 2An apple a day could keep obesity away 2
... Interventional Radiology hailed the Sept. 11 decision by ... has oversight of the 24 recognized medical specialty ... for a new Dual Primary Certificate in Interventional ... and its member boards confirmed the benefit to ...
... JEJU, REPUBLIC OF KOREA (September 12, 2012) A ... biologically diverse place on earth, according to the Wildlife ... list of species found there. The announcement was ... gathering of conservationists meeting through Sept. 13 in Jeju, ...
... a man with apparent battle wounds and curvature of the ... the University of Leicester. The University of Leicester has ... King Richard III with Leicester City Council, in association with ... third week, has yielded dramatic findings of human remains which ...
Cached Biology News:Society of Interventional Radiology hails affirmation of specialty's role in patient care 2Society of Interventional Radiology hails affirmation of specialty's role in patient care 3Society of Interventional Radiology hails affirmation of specialty's role in patient care 4Amazing diversity documented in national park 2King Richard III search in new phase after 'discovery has potential to rewrite history' 2King Richard III search in new phase after 'discovery has potential to rewrite history' 3King Richard III search in new phase after 'discovery has potential to rewrite history' 4King Richard III search in new phase after 'discovery has potential to rewrite history' 5King Richard III search in new phase after 'discovery has potential to rewrite history' 6King Richard III search in new phase after 'discovery has potential to rewrite history' 7King Richard III search in new phase after 'discovery has potential to rewrite history' 8King Richard III search in new phase after 'discovery has potential to rewrite history' 9
... PolarScreen Progesterone Receptor (PR) Competitor ... or screening novel progesterone receptor binding ... homogenous assay utilizes a fusion of ... domain of human progesterone receptor [PR-LBD(GST)] ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential Neurological liabilities of compound...
... form from a hematopoietic stem cells called ... the bone surface and lowering the surrounding ... 4.5. The bone mineral is then solubilized ... function is controlled primarily by Macrophage Colony-Stimulating ...
Biology Products: